|
|
Post by mango on Mar 1, 2017 11:11:13 GMT -5
meeting is merely a legal formality, RS is a done deal was a YES OUTCOME the moment the RS was presented behind closed doors. what most here fail to recognize is- its not about preserving shareholder value at all - its about keeping mnkd alive so those feeding off the company- matt&cronies, the mann family hiers, a few dark pools, some HF's can continue to bleed this turnip until all revenue is gone. Then the major players leave including all Bod/matt an shareholders are left totally in the dust of a failed company. Poorer but hopefully wiser. thk me later for the clarity I bring to a room full of darkness. Are you that same annoying grasshoppapig on Stocktwits? |
|
opera1
Newbie
Posts: 13 
Sentiment: Long
|
Post by opera1 on Mar 1, 2017 11:25:10 GMT -5
WILDPIG skulking/lurking around here from StockTwits spreading more FUD.
Tiresome!!!!
|
|
|
|
Post by uvula on Mar 1, 2017 11:37:47 GMT -5
I suspect if Matt and Mike did attend the meeting people would complain about that also. They both have better things to do to help us and the company.
|
|
|
|
Post by kbrion77 on Mar 1, 2017 11:49:31 GMT -5
I suspect if Matt and Mike did attend the meeting people would complain about that also. They both have better things to do to help us and the company. Unless they are signing a partnership deal I would assume the CEO of the company could take 10 minutes out of his day to attend. Jeffrey Boyd seemed to be pretty active in communication while Priceline went through their reverse split and all we get is, "we are in a position of strength." Bashing Matt is not warranted but complaining about where our shareholder value has gone is. |
|
|
|
Post by silentknight on Mar 1, 2017 12:07:33 GMT -5
I suspect if Matt and Mike did attend the meeting people would complain about that also. They both have better things to do to help us and the company. Unless they are signing a partnership deal I would assume the CEO of the company could take 10 minutes out of his day to attend. Jeffrey Boyd seemed to be pretty active in communication while Priceline went through their reverse split and all we get is, "we are in a position of strength." Bashing Matt is not warranted but complaining about where our shareholder value has gone is. I would agree with you. Matt should be there. It certainly seems pretty disingenuous to me for a BoD and CEO to request shareholders to approve a R/S because they haven't been able to get the job done in selling their product, and then fail to show their faces at the very meeting they've called. To me, it smacks of a concerning lack of respect for shareholders. Either that, or he doesn't want to show his face out of fear of shareholder backlash. I'm sure Matt wants to succeed, but desire alone has proven to be insufficient in achieving success. If he doesn't bother to show up today, paired with his repeated "foot in mouth" mistakes that he's demonstrated himself to be quite adept at and the failure of the company to achieve even the slightest semblance of commercial success, any confidence I have in Matt as CEO will disappear just like my investment has done. Hopefully, he shows but either way, SELL THE DAMNED DRUG! |
|
|
|
Post by peppy on Mar 1, 2017 12:08:00 GMT -5
so someone is going and will give us report? As far as I know one of the men that came to the Temecula dinner is going. I wanted to hitch a ride but I just couldn't miss work. I'll ask him for all the info if he goes. Which I think he is. He wanted to know if anyone from here is going? sports is our person. text messaging. let us know.
|
|
|
|
Post by mango on Mar 1, 2017 13:00:38 GMT -5
Total Shares Outstanding —478,460,000 Short Percent of Float —39.52 % That's cos insider holding is not considered float, so 480 minus insider holdings = 350 of which 100 mil is short Numbers / math Not sure where you got the 40% from but it should be around 30% now My bad, yeah it actually is lower, I am now coming up w/ 31.46% Just logged onto TD Ameritrade and they have the same as of 2/15. Something I just noticed is TD shows institutional ownership at 15.99% and Nasdaq is showing 19.07%. Wonder whose is correct? |
|
|
|
Post by sportsrancho on Mar 1, 2017 13:28:11 GMT -5
As far as I know one of the men that came to the Temecula dinner is going. I wanted to hitch a ride but I just couldn't miss work. I'll ask him for all the info if he goes. Which I think he is. He wanted to know if anyone from here is going? sports is our person. text messaging. let us know.
I'm sure he didn't go. He just wanted to talk to Matt and ask him some questions. At least he was saved a 4 hour drive. I'll get more info if I can:-) |
|
|
|
Post by peppy on Mar 1, 2017 20:40:27 GMT -5
well that post from wildpig didn't last long.
|
|
|
|
Post by roguesuerte on Mar 1, 2017 22:54:01 GMT -5
I have been long this stock since FDA approval and I really thought Afrezza would revolutionize the Diabetes space(I still hope it does very much so I have over 30k share, not going to share my average pps. but I am down big time. I am not going to call mgmt. incompetent inept or incompetent because they have made strides in improved insurance coverage. What I really have trouble coming to terms with is the complete and total lack of any promotion with Afrezza(I just don't get it). You have all these adopters going on twitter, local news, and media outlets while mgmt. sits on their thumbs. I will be very concerned if we don't see a rise in scripts in the next month or so, and there is no advertising whatsoever.
I have a portion of my portfolio in some sketchy energy stocks LNCO, BBEP, and VNR. It seems these days I win mediocre and lose big after several years of investing big and and winning big. My concern is that mgmt. will continue their terrible efforts to sell Afrezza, force dilution and drive the company to BK court where the will miraculously announce they are taking the company private into separate entities like LNCO just did. Their defense could be how could we succeed where SNY failed and MGMT will receive big fees in taking them private. This is my worst case scenario. Nobody disputes whether Afrezza works either long or short, but its not selling well. Efforts to promote and even modest bumps in script numbers would cause shorts to cover and get pps over a buck easy(seems like a no-brainer)
|
|
|
|
Post by onemann on Mar 1, 2017 23:15:31 GMT -5
Speaking of advertising, my wife told me yesterday that she was listening to pandora and heard an ad for Afrezza. Keep your ears open. Hopefully the media blitz is starting. Good Luck
|
|
|
|
Post by surplusvalue on Mar 1, 2017 23:18:10 GMT -5
I have been long this stock since FDA approval and I really thought Afrezza would revolutionize the Diabetes space(I still hope it does very much so I have over 30k share, not going to share my average pps. but I am down big time. I am not going to call mgmt. incompetent inept or incompetent because they have made strides in improved insurance coverage. What I really have trouble coming to terms with is the complete and total lack of any promotion with Afrezza(I just don't get it). You have all these adopters going on twitter, local news, and media outlets while mgmt. sits on their thumbs. I will be very concerned if we don't see a rise in scripts in the next month or so, and there is no advertising whatsoever. I have a portion of my portfolio in some sketchy energy stocks LNCO, BBEP, and VNR. It seems these days I win mediocre and lose big after several years of investing big and and winning big. My concern is that mgmt. will continue their terrible efforts to sell Afrezza, force dilution and drive the company to BK court where the will miraculously announce they are taking the company private into separate entities like LNCO just did. Their defense could be how could we succeed where SNY failed and MGMT will receive big fees in taking them private. This is my worst case scenario. Nobody disputes whether Afrezza works either long or short, but its not selling well. Efforts to promote and even modest bumps in script numbers would cause shorts to cover and get pps over a buck easy(seems like a no-brainer) Do you remember all the cheerleading when MNKD got control back and this was going to be "the great leap forward" ? Didn't quite turn out that way. Now we see cheerleading for round 3. What would you call it then when you burn through 60 million dollars in six months and can barely round up 300 scripts/week and then you come back and say it was a test run? A test run in which you make use of almost half the sales force you led your shareholders to believe was active. This "test run" leads you to a situation where your listing on the exchange is threatened and you have to potentially rely on a shareholders RS to bail you out because you already played the resolution with Sanofi card. Despite their hard work and everything they did accomplish I'd call that incompetence. Lets actually see if they can redeem themselves. |
|
|
|
Post by bradleysbest on Mar 1, 2017 23:28:42 GMT -5
The script numbers the next 3- 6 months will be interesting.... hoping for the best. If not will there be a launch 4.0?
|
|
|
|
Post by peppy on Mar 1, 2017 23:41:51 GMT -5
|
|
|
|
Post by kc on Mar 1, 2017 23:47:56 GMT -5
wildpig your logic only works when you make incorrect assumptions, as is frequently done at Seeking Alpha, then argue against the truth. You will have better luck there than here. Goodbye piggy  Fortunately for me and many other readers we do not even go to SeekingAlpha as that is FUD central. |
|
